ASCO 2020 New prognostic tool predicts cancer recurrence and chemotherapy benefit in early breast cancer Read more
ASCO 2020 Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high m... Read more
ASCO 2020 Maintenance avelumab prolongs the survival of patients with advanced urothelial carcinoma Read more